Post Subject #16   0 ROCK2 inhibitor KD025 was approved for Phase II mcp4 04/19/18 01:26:03 PM #15   0 K-10 was released earlier this month. The mcp4 03/15/18 01:02:32 PM #14   0 Huge buy orders coming in ATVrider 03/09/18 12:44:52 PM #13   0 I hated the way it traded moving down cjstocksup 02/13/18 08:21:33 PM #12   0 Possible bounce play. Bottom looks to be in. INTL 02/13/18 07:57:34 PM #11   0 * * $KDMN Video Chart 02-13-18 * * ClayTrader 02/13/18 05:17:22 PM #10   0 KDMN afterhours news: cjstocksup 02/12/18 04:26:08 PM #9   0 Really not a whole lot going on. mcp4 01/30/18 11:24:51 AM #8   0 quiet board for a stock that is running tayronachan 01/30/18 09:04:49 AM #7   0 KDMN buy 3.56 stocktrademan 06/21/17 05:15:16 PM #6   0 Watching T695 04/06/17 09:27:38 PM #5   0 Another paper, all theory and in vitro work, mcp4 08/24/16 08:19:42 AM #4   0 Preclinical paper for KD025, a ROCK2 inhibitor, for mcp4 08/21/16 01:59:57 AM #3   0 Insider buying! Entered today. Good pipeline IMO. vortmaximum 07/28/16 07:09:03 PM #2   0 KDMN IPO reduced to 6.3M shares at $12. mcp4 07/26/16 03:11:02 PM #1   0 Kadmon shares are expected to price between $16 mcp4 07/26/16 09:17:55 AM Post Subject

© 2018 InvestorsHub.com, Inc.